Improvement of topical therapy of acute nasopharyngitis in conditions of antibiotic resistance

Introduction. The issue of timely diagnosis, treatment and prevention of acute respiratory viral infections (ARVI) and their complications is relevant.

Aim. Тo evaluate the effectiveness of treatment of acute nasopharyngitis with the inclusion of a drug with the active substance silver proteinate in complex therapy.

Materials and methods. The study was conducted with the participation of 67 children of the younger age group of 7–10 years, including girls (n = 33) and boys (n = 34), with a verified diagnosis of acute nasopharyngitis (runny nose), J-00, who were divided into two groups. In addition to the standard treatment, children in the main group (n = 35) received a drug with antimicrobial and anti-inflammatory effects with an active substance in silver proteinate for 7 days, and children in the control group (n = 32) received standard treatment for acute nasopharyngitis, according to clinical recommendations. The complaints raised the coefficient of poor living conditions for patients, according to the results of the PSOM-31 questionnaire. The control points were on the 5^th and 7^th day after the start of treatment.

Results and discussion. In patients of both groups, there was a decrease in the severity of subjective and objective symptoms of the disease, and to a greater extent in children who additionally took the drug with silver proteinate content. The best indicators of relief of nasopharyngeal symptoms by the 7^th day of treatment were recorded in individuals of the first group: a decrease in rhinorrhea by 26% and postnasal congestion by 65.5%. On day 7, the “general symptoms” worried the patients of the second group to a greater extent than those of the first group and were equal to 7.4 and 14.9 points according to the results of the PSOM-31 questionnaire, respectively. Patients of both groups receiving conservative therapy did not register any manifestations of allergies and side effects.

Conclusion. The topical use of silver proteinate in the complex therapy of acute nasopharyngitis reduces local inflammatory manifestations in the nasopharynx, promotes an earlier recovery period, and is well tolerated by patients.

1. Пальчун ВТ (ред.). Оториноларингология: национальное руководство. 2-е изд., перераб. и доп. 6М0.: ГЭОТАР-Медиа; 2022. 1024 с. Режим доступа: https://www.rosmedlib.ru4/b0ook/ISBN9785970466698.html.

2. Hellings PW, Borrelli D, Pietikainen S, Agache I, Akdis C, Bachert C et al. European Summit on the2P0revention and Self-Management of ChronicRespiratory Diseases: report of the European Union Parliament Summit (29 March 2017). Clin Transl Allergy. 2017;(7):49. https://doi.org/10.1186/s13601-017-0186-3.

3. Korkmazov MYu, Kornova NV, Lengina MA, Smirnov AA, Korkmazov AM, Dubinets ID. Effective antibiotic therapy for community-acquired otorhinolaryngological respiratory infection (clinical description). Meditsinskiy Sovet. 2022;16(20):73–81. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-20-73-81.

4. Osidak LV, Dondurey EA, Obraztsova EV, Golovacheva EG, Afanasyeva OI. The structure of morbidity and modern approaches to the treatment of ARVI in children. breast cancer. RMJ. Medical Review. 2019;(3):33–38. (In Russ.) Available at: https://www.rmj.ru/articles/pediatriya/Struktura_zabolevaemosti_i_sovremennye_podhody_k_terapii_ORVI_u_detey.

5. Giesinger OA, Korkmazov MU, Shchetinin SA. Immunostimulating therapy for chronic adenoiditis in children. Vrach. 2015;(9):25–28. (In Russ.) Available at: https://elibrary.ru/ukxagz.

6. Weldon D. Diagnosis and management of rhinitis. Prim Care. 1998;25(4):831–848. https://doi.org/10.1016/s0095-4543(05)70091-9.

7. Buensalido JAL, Valencia JCB, Brusch JL (eds.). Rhinovirus (RV) Infection (Common Cold). Medscape. 2019;25. Available at: https://emedicine.medscape.com/article/227820-overview.

8. Ryazantsev SV, Krivopalov AA, Eremin SA, Zakharova GP, Shabalin VV, Shapkina PA, Chufistova AV. Topical antibacterial therapy of acute rhinosinusitis. RMJ. 2020;(4):2–7. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Topicheskaya_antibakterialynaya_terapiya_ostrogo_rinosinusita/?ysclid=m8ct0zspsl430992270.

9. Чуланов ВП, Горелов АВ, Малявин АГ, Зайцев АА, Малеев ВВ, Арсланова ЛВ и др. Острые респираторные вирусные инфекции (ОРВИ) у взрослых: клинические рекомендации. М.; 2021. 70 с. Режим доступа: https://www.rnmot.ru/public/uploads/RNMOT/clinical/2021/КР%20ОРВИ.pdf.

10. Баранов АА, Намазова-Баранова ЛС, Лобзин Ю В, Таточенко ВК, Усков АН Куличенко ТВ и др. Острая респираторная вирусная инфекция (ОРВИ) у детей: клинические рекомендации. 2022. М.; 2022. 34 с. Режим доступа: https://diseases.medelement.com/disease/острая-респираторная-вирусная-инфекция-орви-у-детей-кп-рф-2022/17350.

11. Karpishchenko SA Krivopalov AA, Eremin SA, Shapkina PA, Chufistova AV. Topical antimicrobial therapy of infectious and inflammatory diseases of the nose and paranasal sinuses. RMJ. 2020;(5):26–30. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Topicheskaya_antimikrobnaya_terapiya_infekcionno-vospalitelynyh_zabolevaniy_nosa_i_okolonosovyh_pazuh.

12. Korkmazov MYu, Lengina MA, Korkmazov АM, Kornova NV, Beloshangin АS. Treatment and prevention of various forms of laryngitis on the background of acute respiratory infections. Meditsinskiy Sovet. 2022;16(8):79–87. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-8-79-87.

13. Korkmazov MYu. Chronic tonsillitis and analysis of physical methods of exposure. Vestnik Oto-Rino-Laringologii. 2006;(Suppl. 5):299–300. (In Russ.) Available at: https://www.elibrary.ru/sicbel.

14. Podkopaeva Yu, Krivopalov AA. Сurrent understanding of the diagnosis and treatment of chronic bilateral laryngeal paralytic stenosis. Rossiiskaya Otorinolaringologiya. 2013;(6):146–155. (In Russ.) Available at: https://med-click.ru/uploads/files/docs/sovremennye-predstavleniya-o-diagnostike-i-lechenii-hronicheskih-dvustoronnih-paraliticheskih-stenozov-gortani-literaturnyy-obzor.pdf.

15. Korkmazov MYu, Angelovich MS, Lengina MA, Belousov SYu. Clinical case of angiosarcoma of ethmoidal labyrinth and frontal sinus, issues of morphological verification of diagnosis. Vestnik Oto-Rino-Laringologii. 2022;87(4):102–106. (In Russ.) https://doi.org/10.17116/otorino202287041102.

16. Orlova NV. Complex therapy of acute respiratory diseases. Meditsinskiy Sovet. 2019;(15):91–97. (In Russ.) https://doi.org/10.21518/2079-701X-2019-15-91-97.

17. Hisamova AA, Giesinger OA, Kornova NV, Zyryanova KS, Korkmazov AM, Beloshangin AS. Studies of immunological and microbiological efficiency of the therapy of curcumin and methionine in the developed capsules. Russian Journal of Immunology. 2021;24(2):305–310. (In Russ.) https://doi.org/10.46235/1028-7221-1001-SOI.

18. Giesinger ОA, Korkmazov MYu, Shchetinin SA. The specific aspects of anamnesis of children with chronic adenoiditis. Rossiiskaya Otorinolaringologiya. 2017;(3):24–29. (In Russ.) https://doi.org/10.18692/1810-4800-2017-3-24-29.

19. Korkmazov MYu, Lengina MA, Korkmasova M, Kravchenko AYu. Effect of post-COVID syndrome on the quality of life of patients with allergic rhinitis and eosinophilic phenotype of chronic polyposis rhinosinusitis. Medical Journal of the Russian Federation. 2023;29(4):277–290. (In Russ.) https://doi.org/10.17816/medjrf472079.

20. Zyryanova KS, Dubinets ID, Korkmazov MY, Solodovnik AV. Differentiated approach to the treatment of exudative otitis media with application mucoregulatory therapy in childhood. Russian Otorhinolaryngology. 2014;(2):31–34. (In Russ.) Available at: https://elibrary.ru/ryyujp.

21. Krivopalov AA, Yanov YuK, Shatalov VA, Rubin AN, Shcherbuk AYu, Artyushkin SA et al. Clinicodiagnostic features of otorhinosinusogenic intracranial pyoinflammatory diseases complicated by sepsis. Grekov’s Bulletin of Surgery. 2016;175(6):13–19. (In Russ.) https://doi.org/10.24884/0042-4625-2016-175-6-13-19.

22. Beceiro A, Tomás M, Bou G. Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin Microbiol Rev. 2013;26(2):185–230. https://doi.org/10.1128/CMR.00059-12.

23. Korkmazov MYu, Solodovnik AV, Korkmazov AM, Lengina MA. Prospects for using herbal preparation in combination with physical methods in complex therapy of chronic adenoiditis. Meditsinskiy Sovet. 2021;(18):19–27. (In Russ.) https://doi.org/10.21518/2079-701X-2021-18-19-27.

24. Zyryanova KS, Dubinets ID, Ershova IS, Korkmazov MYu. Initial therapy of acute otitis media in children. Vrach. 2016;(1):43–45. (In Russ.) Available at: https://elibrary.ru/vrxvph.

25. Pavlova SS, Korneenkov AA, Dvorianchikov VV, Ryazantsev SV, Ryazantseva ES, Donskaya OS. Assessment of population health losses due to nasal obstruction based on the concept of the global burden of disease: general approaches and research directions. Meditsinskiy Sovet. 2021;(12):138–145. (In Russ.) https://doi.org/10.21518/2079-701X-2021-12-138-145.

26. Korkmazov MYu, Kazachkov EL, Lengina MA, Dubinets ID, Korkmazov AM. Cause-effect factors of rhinosinusitis poliposa development. Russian Rhinology. 2023;31(2):124–130. (In Russ.) https://doi.org/10.17116/rosrino202331021124.

27. Ozkaya-Parlakay A, Uysal M, Kara A. Group A streptococcal tonsillopharyngitis burden in a tertiary Turkish hospital. Turk J Pediatr. 2012;54(5):474–477. Available at: https://pubmed.ncbi.nlm.nih.gov/23427509.

28. Meegalla N, Downs BW. Anatomy, Head and Neck, Palatine Tonsil (Faucial Tonsils). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. Available at: https://pubmed.ncbi.nlm.nih.gov/30855880.

29. Stelter K. Tonsillitis and sore throat in children. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2014;13:Doc07. https://doi.org/10.3205/cto000110.

30. Самсыгина ГА. Острые респираторные заболевания у детей. М.: ГЭОТАР-Медиа; 2019. 224 с. Режим доступа: https://www.rosmedlib.ru/book/ISBN9785970451052.html.

31. Korkmazov MY, Yastremsky AP, Kornova NV, Lengina MA, Korkmazov AM. Therapeutic and diagnostic approaches in the treatment of chronic tonsillitis. Meditsinskiy Sovet. 2022;16(20):90–99. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-20-90-99.

32. Shchetinin SA, Korkmazov MYu, Giesinger OA, Kochengina SA, Sokol EV. Efficiency of therapy ofchronic recurrent adenoiditisfor the children of resident in city Chelyabinsk on results front active rhinomanometriaandcytokine profile of washings of from the surface of oesophageal amygdale. Bulletin of the Chelyabinsk Regional Clinical Hospital. 2015;(3):59–63 (In Russ.) Available at: https://elibrary.ru/yjjnhh.

33. Korkmazov MU. The theory of bioresonance and the possibility of its application in ENT practice. Russian Otorhinolaryngology. 2009;(2):92–96. (In Russ.) Available at: https://elibrary.ru/mgszax.

34. Karpishchenko SA, Fatalieva AF. Modern concept of acute rhinosinusitis treatment. RMJ. Medical Review. 2019;3(9-2):93–96. (In Russ.) Available at: https://www.rusmedreview.com/articles/otorinolaringologiya/Sovremennaya_koncepciya_lecheniya_ostrogo_rinosinusita.

35. Korkmazov MYu, Lengina MA, Korkmazov AM. Biochemical parameters of the nature of oxidative stress depending on the performed postoperative therapy in patients who underwent intra-nasal surgical interventions. Vestnik Oto-Rino-Laringologii. 2016;81(Suppl. 5):33–35. (In Russ.) Available at: https://elibrary.ru/ylvebm.

36. Thomas M, Bomar PA. Upper Respiratory Tract Infection. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available at: https://pubmed.ncbi.nlm.nih.gov/30422556.

37. Krett JD, Beckham JD, Tyler KL, Piquet AL, Chauhan L, Wallace CJ et al. Neurology of Acute Viral Infections. Neurohospitalist. 2022;12(4):632–646. https://doi.org/10.1177/19418744221104778.

38. Pappas DE, Hendley JO, Hayden FG, Winther B. Symptom profile of common colds in school-aged children. Pediat Infect Dis J. 2008;27(1):8–11. https://doi.org/10.1097/inf.0b013e31814847d9.

39. Scott JR, Krishnan R, Rotenberg BW, Sowerby LJ. The effectiveness of topical colloidal silver in recalcitrant chronic rhinosinusitis: a randomized crossover control trial. J Otolaryngol Head Neck Surg. 2017;46(1):64. https://doi.org/10.1186/s40463-017-0241-z.

40. O’Neill J. (eds) Tackling drug-resistant infections globally: final report and recommendations. London, England: Review on Antimicrobial Resistance; 2016. 80 p. Available at: https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf.

41. Shin SH, Ye MK. The effect of nano-silver on allergic rhinitis model in mice. Clin Exp Otorhinolaryngol. 2012;5(4):222–227. https://doi.org/10.3342/ceo.2012.5.4.222.

42. Янов ЮК, Крюков АИ, Дворянчиков ВВ. Оториноларингология: национальное руководство. М.: ГЭОТАР-Медиа; 2024. 992 с.

43. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res. 2000;52(4):662–668. https://doi.org/10.1002/1097-4636(20001215)52:4<662:aid-jbm10>3.0.co;2-3.

44. Slawson RM, Lee H, Trevors JT. Bacterial interactions with silver. Biol Met. 1990;3(3-4):151–154. https://doi.org/10.1007/BF01140573.

45. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76–83. https://doi.org/10.1016/j.biotechadv.2008.09.002.

46. Goggin R, Jardeleza C, Wormald PJ, Vreugde S. Colloidal silver: a novel treatment for Staphylococcus aureus biofilms? Int Forum Allergy Rhinol. 2014;4(3):171–175. https://doi.org/10.1002/alr.21259.